ZHONGZHIPHARM(03737) issues a profit warning, expecting a decrease in annual net profit of no less than 70%.

20:44 23/01/2026

Zhongzhi Pharmaceutical (03737) announced that it expects the annual net profit for the year ending December 31, 2025, to decrease by no less than 70% compared to the year ending December 31, 2024. In 2025, due to industry policy adjustments leading to a temporary decline in sales revenue and profit being affected to some extent, the Group will maintain its market investment efforts and actively explore new business growth opportunities.

ZHONGZHIPHARM (03737) announced that it is expected that the net profit for the full year ending December 31, 2025 will decline by no less than 70% compared to the full year ending December 31, 2024. In 2025, due to industry policy adjustments leading to a short-term decrease in sales revenue, profits will be somewhat affected. The Group will continue to maintain market investment efforts and actively explore new business growth opportunities.

Tianli International Holdings Ltd (01773) has obtained the director, chairman and CEO Luo Shizeng who holds an additional 300,000 shares.

US Stock Market Move | Q1 performance guidance lower than expected, Intel Corporation (INTC.US) plummets nearly 13% in pre-market trading.

HANXBIO-B(03378): The stable price period ends, there will be no stable price actions and the oversubscribed rights issue will be invalid.

Tianli International Holdings Ltd (01773) has obtained the director, chairman and CEO Luo Shizeng who holds an additional 300,000 shares.

US Stock Market Move | Q1 performance guidance lower than expected, Intel Corporation (INTC.US) plummets nearly 13% in pre-market trading.

HANXBIO-B(03378): The stable price period ends, there will be no stable price actions and the oversubscribed rights issue will be invalid.